External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience MDA 2022
Roche and Genentech at

MDA 2022

March 13 - March 16
Nashville, USA / Virtual (Hybrid)
mdaconference.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Highlights
Coming soon
08:20 AM
Duration 15mins Gaylord Opryland Resort & Convention Center, Tennessee Ballroom
SUNFISH Parts 1 and 2: 3-year efficacy and safety of risdiplam▼ in Types 2 and 3 spinal muscular atrophy (SMA)
John W Day, Nicolas Deconinck, Janbernd Kirschner, Elena S Mazzone, Andres Nascimento, Maryam Oskoui, Kayoko Saito, Carole Vuillerot, Giovanni Baranello, Odile Boespflug-Tanguy, Nathalie Goemans, Anna Kostera-Pruszczyk, Laurent Servais, Jessica Braid, Marianne Gerber, Ksenija Gorni, Carmen Martin, Renata S Scalco, Wai Yin Yeung, Eugenio Mercuri on behalf of the SUNFISH Working Group
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.